Fresh off earning an updated FDA clearance for its flagship neuromodulation device, Mainstay Medical has closed an equity financing round to help expand the device’s global presence. The Irish company ...

Low back pain is the biggest musculoskeletal issue affecting the world today. At any given moment, up to 33 percent of the population is dealing with low back pain. It is one of the most common ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (the “Company”) today announced the limited commercial launch in the U.S. of ReActiv8, its implantable Restorative Neurostimulation™ system to ...

The Company previously announced a modification of the implant surgical approach to mitigate the risk of conductor fractures inside the lead, which had been observed in the ReActiv8-A Trial at that ...